AC T10472
XX
ID T10472
XX
DT 10.03.2005 (created); nvo.
DT 10.05.2015 (updated); jmh.
CO Copyright (C), QIAGEN.
XX
FA Fli-1
XX
SY Erg-B; friend leukemia integration site 1.
XX
OS Mammalia
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia
XX
IN T15204 brca1; Mammalia.
IN T08499 CBP; mouse, Mus musculus.
IN T09278 IRF-4-isoform1; mouse, Mus musculus.
IN T14063 SRF; Mammalia.
XX
MX M08881 V$ETSLIKE_Q4.
MX M00771 V$ETS_Q4.
MX M00971 V$ETS_Q6.
MX M07382 V$FLI1_Q5.
MX M01208 V$FLI1_Q6.
XX
BS R25595.
BS R64846.
BS R64850.
BS R64851.
BS R21052.
BS R25528.
BS R25529.
BS R31564.
BS R67554.
BS R26372.
BS R04065.
XX
DR TRANSPATH: MO000047757.
DR TRANSCOMPEL: C00032.
XX
RN [1]; RE0015489.
RX PUBMED: 8604338.
RA Magnaghi-Jaulin L., Masutani H., Robin P., Lipinski M., Harel-Bellan A.
RT SRE elements are binding sites for the fusion protein EWS-FLI-1
RL Nucleic Acids Res. 24:1052-1058 (1996).
RN [2]; RE0016555.
RX PUBMED: 9551977.
RA Perkel J. M., Atchison M. L.
RT A two-step mechanism for recruitment of Pip by PU.1
RL J. Immunol. 160:241-252 (1998).
RN [3]; RE0024587.
RX PUBMED: 10606656.
RA Dalgleish P., Sharrocks A. D.
RT The mechanism of complex formation between Fli-1 and SRF transcription factors.
RL Nucleic Acids Res. 28:560-569 (2000).
RN [4]; RE0028855.
RX PUBMED: 10194443.
RA Bastian L. S., Kwiatkowski B. A., Breininger J., Danner S., Roth G.
RT Regulation of the megakaryocytic glycoprotein IX promoter by the oncogenic Ets transcription factor Fli-1.
RL Blood 93:2637-44 (1999).
RN [5]; RE0045775.
RX PUBMED: 12556498.
RA Starck J., Cohet N., Gonnet C., Sarrazin S., Doubeikovskaia Z., Doubeikovski A., Verger A., Duterque-Coquillaud M., Morle F.
RT Functional cross-antagonism between transcription factors FLI-1 and EKLF
RL Mol. Cell. Biol. 23:1390-402 (2003).
RN [6]; RE0046278.
RX PUBMED: 12359731.
RA Holmes M. L., Bartle N., Eisbacher M., Chong B. H.
RT Cloning and analysis of the thrombopoietin-induced megakaryocyte-specific glycoprotein VI promoter and its regulation by GATA-1, Fli-1, and Sp1
RL J. Biol. Chem. 277:48333-41 (2002).
RN [7]; RE0049157.
RX PUBMED: 15273724.
RA Ramakrishnan R., Fujimura Y., Zou J. P., Liu F., Lee L., Rao V. N., Reddy E. S.
RT Role of protein-protein interactions in the antiapoptotic function of EWS-Fli-1.
RL Oncogene 23:7087-7094 (2004).
RN [8]; RE0067181.
RX PUBMED: 11313879.
RA Chai Y., Chipitsyna G., Cui J., Liao B., Liu S., Aysola K., Yezdani M., Reddy E. S., Rao V. N.
RT c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells.
RL Oncogene 20:1357-1367 (2001).
RN [9]; RE0071919.
RX PUBMED: 19158279.
RA Asano Y., Trojanowska M.
RT Phosphorylation of Fli1 at threonine 312 by protein kinase C delta promotes its interaction with p300/CREB-binding protein-associated factor and subsequent acetylation in response to transforming growth factor beta.
RL Mol. Cell. Biol. 29:1882-1894 (2009).
XX
//